198 related articles for article (PubMed ID: 37091947)
1. Mechanistic Considerations in 1,4-Dioxane Cancer Risk Assessment.
Ginsberg G; Chen Y; Vasiliou V
Curr Opin Environ Sci Health; 2022 Dec; 30():. PubMed ID: 37091947
[TBL] [Abstract][Full Text] [Related]
2. Update: Mode of action (MOA) for liver tumors induced by oral exposure to 1,4-dioxane.
Dourson ML; Higginbotham J; Crum J; Burleigh-Flayer H; Nance P; Forsberg ND; Lafranconi M; Reichard J
Regul Toxicol Pharmacol; 2017 Aug; 88():45-55. PubMed ID: 28366800
[TBL] [Abstract][Full Text] [Related]
3. In vivo positive mutagenicity of 1,4-dioxane and quantitative analysis of its mutagenicity and carcinogenicity in rats.
Gi M; Fujioka M; Kakehashi A; Okuno T; Masumura K; Nohmi T; Matsumoto M; Omori M; Wanibuchi H; Fukushima S
Arch Toxicol; 2018 Oct; 92(10):3207-3221. PubMed ID: 30155721
[TBL] [Abstract][Full Text] [Related]
4. An integrated assessment of the 1,4-dioxane cancer mode of action and threshold response in rodents.
Lafranconi M; Anderson J; Budinsky R; Corey L; Forsberg N; Klapacz J; LeBaron MJ
Regul Toxicol Pharmacol; 2023 Aug; 142():105428. PubMed ID: 37277058
[TBL] [Abstract][Full Text] [Related]
5. Weight of evidence analysis of the tumorigenic potential of 1,3-dichloropropene supports a threshold-based risk assessment.
Yan ZJ; Bartels M; Gollapudi B; Driver J; Himmelstein M; Gehen S; Juberg D; van Wesenbeeck I; Terry C; Rasoulpour R
Crit Rev Toxicol; 2020 Nov; 50(10):836-860. PubMed ID: 33528302
[TBL] [Abstract][Full Text] [Related]
6. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, glutathione, and CYP2E1 in 1,4-dioxane liver cytotoxicity and genotoxicity: insights from animal models.
Wang Y; Charkoftaki G; Davidson E; Orlicky DJ; Tanguay RL; Thompson DC; Vasiliou V; Chen Y
Curr Opin Environ Sci Health; 2022 Oct; 29():. PubMed ID: 37483863
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and genotoxicity in 1,4-dioxane liver toxicity as evidenced in a mouse model of glutathione deficiency.
Chen Y; Wang Y; Charkoftaki G; Orlicky DJ; Davidson E; Wan F; Ginsberg G; Thompson DC; Vasiliou V
Sci Total Environ; 2022 Feb; 806(Pt 2):150703. PubMed ID: 34600989
[TBL] [Abstract][Full Text] [Related]
9. Mode of action analysis for liver tumors from oral 1,4-dioxane exposures and evidence-based dose response assessment.
Dourson M; Reichard J; Nance P; Burleigh-Flayer H; Parker A; Vincent M; McConnell EE
Regul Toxicol Pharmacol; 2014 Apr; 68(3):387-401. PubMed ID: 24491968
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk assessment for dioxane based upon a physiologically-based pharmacokinetic approach.
Leung HW; Paustenbach DJ
Toxicol Lett; 1990 Apr; 51(2):147-62. PubMed ID: 2158678
[TBL] [Abstract][Full Text] [Related]
12. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
14. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
15. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
17. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
[TBL] [Abstract][Full Text] [Related]
18. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
McGregor D
Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
[TBL] [Abstract][Full Text] [Related]
19. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
Butterworth BE; Conolly RB; Morgan KT
Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
[TBL] [Abstract][Full Text] [Related]
20. Arsenic-induced bladder cancer in an animal model.
Cohen SM; Ohnishi T; Arnold LL; Le XC
Toxicol Appl Pharmacol; 2007 Aug; 222(3):258-63. PubMed ID: 17109909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
